Emicizumab-kxwh Subcutaneous and Letermovir Injection
Determining the interaction of Emicizumab-kxwh Subcutaneous and Letermovir Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: letermovir
Brand name: Prevymis
Synonyms: Letermovir (oral/injection), Letermovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Letermovir Intravenous
- Emicizumab-kxwh Subcutaneous-Letermovir oral/injection
- Emicizumab-kxwh Subcutaneous-Letermovir Tablets
- Emicizumab-kxwh Subcutaneous-Letrozole
- Emicizumab-kxwh Subcutaneous-Letrozole and ribociclib
- Emicizumab-kxwh Subcutaneous-Leucovorin
- Letermovir Injection-Emla
- Letermovir Injection-Emla Topical
- Letermovir Injection-Emo-Cort Scalp Solution Topical application
- Letermovir Injection-Emo-Cort Topical application
- Letermovir Injection-Emoquette
- Letermovir Injection-Empagliflozin